STOCK TITAN
  1. Home
  2. Sec-filings
  3. SNX
  4. [Form 4] TD SYNNEX CORP Insider Trading Activity

TD SYNNEX CORP (NYSE: SNX) CFO sells 861 shares under Rule 10b5-1 plan

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

TD SYNNEX CORP Chief Financial Officer Witt Marshall reported an option exercise and related share sale. On September 17, 2025, he exercised 861 Employee Stock Options at $57.34 per share to acquire 861 common shares, then sold 861 common shares at $149.84 per share. The sale was effected under a Rule 10b5-1 trading plan adopted on May 12, 2025. After these transactions, he holds 49,777 common shares directly and retains 7,749 stock options expiring October 4, 2026.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine option exercise and simultaneous sale under a pre-established 10b5-1 plan; no new compensation or material dilution disclosed.

The filing shows a typical insider liquidity event: an exercise of 861 option shares at $57.34 and an immediate sale of 861 shares at $149.84 executed under a Rule 10b5-1 plan. The option pool position remaining is 7,749 option shares with specified vesting terms. These actions appear mechanical—converting option value to cash—rather than signaling a change in company fundamentals. No information about company-wide share counts or material impact on capitalization is provided in the form.

TL;DR: Transactions follow governance best practices by using a documented 10b5-1 plan; timing and disclosures are consistent with compliance.

The reporting person used a Rule 10b5-1 plan adopted on May 12, 2025, to execute a matched exercise and sale on 09/17/2025, which supports compliance with insider trading rules. Vesting details for the employee stock option are disclosed: 20% vests on the first anniversary of grant and then 1/60th monthly. The form is properly signed by an attorney-in-fact. There are no disclosures here of unusual governance events or deviations from standard disclosure practice.

Insider Witt Marshall
Role Chief Financial Officer
Sold 861 shs ($129K)
Approx. gross sale proceeds $129K
Approx. exercise cost $49K
Approx. pre-tax spread $80K
Type Security Shares Price Value
Exercise Employee Stock Option (Right to Buy) 861 $0.00 $0.00
Exercise Common Stock 861 $57.34 $49K
Sale Common Stock 861 $149.84 $129K
Holdings After Transaction: Employee Stock Option (Right to Buy) — 7,749 shares (Direct); Common Stock — 49,777 shares (Direct)
Footnotes (2)
  1. F1. These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.
  2. F2. This stock option vests as to 20% of the shares on the first anniversary of the date of grant and vests as to 1/60th of the shares monthly thereafter.
Shares sold 861 shares Common Stock sold on September 17, 2025
Sale price $149.84 per share Price for 861 Common Stock shares sold
Option exercise price $57.34 per share Exercise price for 861 Employee Stock Options
Options exercised 861 options Employee Stock Options (Right to Buy) exercised into Common Stock
Options remaining 7,749 options Employee Stock Options remaining after the reported exercise, expiring October 4, 2026
Post-transaction share holdings 49,777 shares Direct Common Stock holdings after the reported transactions
10b5-1 plan adoption date May 12, 2025 Date the Rule 10b5-1 trading plan governing the sale was adopted
Rule 10b5-1 trading plan regulatory
"These sales were effectuated pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Employee Stock Option (Right to Buy) financial
"security_title: Employee Stock Option (Right to Buy)"
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did TD SYNNEX (SNX) CFO Witt Marshall report?
CFO Witt Marshall reported an option exercise and matching sale of 861 shares. He exercised stock options at $57.34 per share and sold the resulting common shares at $149.84 per share on September 17, 2025, under a pre-arranged Rule 10b5-1 plan.

How many TD SYNNEX (SNX) shares did the CFO sell and at what price?
The CFO sold 861 common shares of TD SYNNEX at an average price of $149.84 per share. These shares came from exercising employee stock options the same day, creating a combined exercise-and-sell transaction sequence reported in this Form 4 filing.

What stock options did the TD SYNNEX (SNX) CFO exercise in this filing?
He exercised 861 Employee Stock Options with an exercise price of $57.34 per share. Following this exercise, the option position shows 7,749 options remaining outstanding for the same award, which is scheduled to expire on October 4, 2026.

How many TD SYNNEX (SNX) shares does the CFO hold after these transactions?
After the reported transactions, the CFO directly holds 49,777 shares of TD SYNNEX common stock. This post-transaction holding reflects his remaining equity stake, separate from the 7,749 stock options that continue to be outstanding under the reported option award.

Was the TD SYNNEX (SNX) CFO’s stock sale made under a Rule 10b5-1 plan?
Yes, the reported sale of 861 shares was effected pursuant to a Rule 10b5-1 trading plan. The plan was adopted by the reporting person on May 12, 2025, indicating the sale followed a pre-established, automated trading arrangement.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Witt Marshall
(Last) (First) (Middle)
44201 NOBEL DRIVE
(Street)
FREMONT CA 94538
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TD SYNNEX CORP [ SNX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/17/2025 M 861 A $57.34 50,638 D
Common Stock 09/17/2025 S(1) 861 D $149.84 49,777 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $57.34 09/17/2025 M 861 (2) 10/04/2026 Common Stock 861 $0 7,749 D
Explanation of Responses:
1. These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.
2. This stock option vests as to 20% of the shares on the first anniversary of the date of grant and vests as to 1/60th of the shares monthly thereafter.
/s/ Cheryl Grant, attorney-in-fact 09/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR